Saturn V Capital Management

Saturn V Capital Management as of June 30, 2023

Portfolio Holdings for Saturn V Capital Management

Saturn V Capital Management holds 20 positions in its portfolio as reported in the June 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Chinook Therapeutics 11.2 $20M 525k 38.42
Crinetics Pharmaceuticals In (CRNX) 9.4 $17M 939k 18.02
Cogent Biosciences (COGT) 7.5 $14M 1.1M 11.84
Cytokinetics Com New (CYTK) 7.3 $13M 406k 32.62
Cymabay Therapeutics 7.2 $13M 1.2M 10.95
Kalvista Pharmaceuticals (KALV) 7.0 $13M 1.4M 9.00
Biogen Idec (BIIB) 6.5 $12M 41k 284.85
Horizon Therapeutics Pub L SHS 5.7 $10M 100k 102.85
Apellis Pharmaceuticals (APLS) 5.4 $9.8M 107k 91.10
Morphic Hldg (MORF) 4.8 $8.7M 152k 57.33
Iteos Therapeutics (ITOS) 4.7 $8.4M 636k 13.24
BioMarin Pharmaceutical (BMRN) 4.5 $8.0M 93k 86.68
Ascendis Pharma A/s Sponsored Adr (ASND) 3.9 $7.0M 78k 89.25
BioCryst Pharmaceuticals (BCRX) 3.7 $6.7M 955k 7.04
Sarepta Therapeutics (SRPT) 3.4 $6.2M 54k 114.52
Astria Therapeutics (ATXS) 2.9 $5.3M 638k 8.33
Syndax Pharmaceuticals (SNDX) 2.0 $3.6M 174k 20.93
Sage Therapeutics (SAGE) 1.8 $3.3M 71k 47.02
Argenx Se Sponsored Adr (ARGX) 0.9 $1.6M 4.1k 389.73
Scilex Holding (SCLX) 0.0 $58k 10k 5.57